obesity-995x60.png
FEATURED ARTICLES
Defining Meaningful Anti-Inflammatory Response: What Early Human Data Tells Us
Controlled immune challenges link drug exposure to biological effects, helping refine dose selection, test mechanisms and support better decisions before patient trials.
-
![cancer cell screening, disease treatment medical-GettyImages-2176920684]( "Resensitizing Treatment-Resistant Cancer Holds Promise Over Replacing Once-Efficacious Therapies")
Resensitizing Treatment-Resistant Cancer Holds Promise Over Replacing Once-Efficacious TherapiesJohn Yu, MD, of Kairos Pharma, explains why reversing treatment resistance could extend the life of proven cancer therapies and improve patient outcomes.
-
![Digital brain, AI, Machine Learning, AI Neural Network-GettyImages-2238702869]( "AI, Open Source, & the Future of Biostatistics")
AI, Open Source, & the Future of BiostatisticsAI and open-source tools are changing statistical programming. Learn how to validate, govern, and apply them without sacrificing the accuracy and oversight clinical research demands.
-
![business man looking through telescope-GettyImages-2215651052]( "Why Oncology Programs Can't Rely On An Inside View Alone")
Why Oncology Programs Can't Rely On An Inside View AloneDiscover how looking outside a program can help oncology teams test assumptions, improve feasibility, and make stronger development decisions.
SERVICES AND PRODUCTS
DECODE, the Digital Endpoint Collaboration for Outcomes Development, is Ametris’ pre-competitive collaboration framework designed to help address shared clinical measurement challenges across the life sciences industry. In regulatory contexts where evidence expectations are high, digital measures must be meaningful to patients, scientifically valid, operationally feasible, and aligned with regulatory expectations. By supporting the development and validation of fit-for-purpose, patient-centered digital measures, DECODE helps transform real-world data into validated clinical evidence across clinical research programs.
YpsoDose supports a broad range of formulation and injection requirements. Its intuitive design ensures reliable, comfortable injections across conditions and environments.
Mobile ophthalmic clinical research and clinical trial on-site support services designed to address challenges across all trial phases and ensure reliable protection of ocular endpoints.
From enabling connected clinical trials to supporting digital therapy management, our solutions help improve clinical trial operational efficiency and data quality, strengthen commercial success, and empower patients to self-manage their therapy.
With experience across 360+ rare disease studies and 125+ indications, explore how specialized expertise and patient-focused delivery help advance clinical programs.